Dactolisib

CAS No. 915019-65-7

Dactolisib ( NVP-BEZ235;BEZ-235 )

Catalog No. M16571 CAS No. 915019-65-7

A potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 35 In Stock
50MG 47 In Stock
100MG 58 In Stock
200MG 97 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dactolisib
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively.
  • Description
    A potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively; effectively and specifically blocks the dysfunctional activation of the PI3K pathway, inducing G(1) arrest; demonstrates antitumor activity in in vivo models of human cancer.Kidney Cancer Phase 2 Discontinued
  • Synonyms
    NVP-BEZ235;BEZ-235
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    ATR;mTOR(p70S6K);p110α;p110γ;p110δ;p110β
  • Research Area
    Cancer
  • Indication
    Kidney Cancer

Chemical Information

  • CAS Number
    915019-65-7
  • Formula Weight
    469.54
  • Molecular Formula
    C30H23N5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 8.75 mg/mL
  • SMILES
    CC(C1=CC=C(N(C2=C3C=NC4=CC=C(C5=CC6=CC=CC=C6N=C5)C=C24)C(N3C)=O)C=C1)(C)C#N
  • Chemical Name
    Benzeneacetonitrile, 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-.alpha.,.alpha.-dimethyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Maira SM, et al. Mol Cancer Ther. 2008 Jul;7(7):1851-63.
2. Serra V, et al. Cancer Res. 2008 Oct 1;68(19):8022-30.
3. Schnell CR, et al. Cancer Res. 2008 Aug 15;68(16):6598-607.
molnova catalog
related products
  • LTURM34

    LTURM34 is an inhibitor of DNA-PK with IC50 of 34 nM. LTURM34 displays effective antiproliferative activity in a wide range of tumor cell lines.

  • IPI-3063

    IPI-3063 is an effective and selective inhibitor of PI3K p110δ (IC50: 2.5?±?1.2 nM).

  • PQR-530

    PQR-530 (PQR530) is a potent, BBB penetrant, dual pan-PI3K/mTOR inhibitor.